{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:11:56Z","timestamp":1790485916374,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.numecd.2019.09.018","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T12:27:55Z","timestamp":1569846475000},"page":"292-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6506-8397","authenticated-orcid":false,"given":"Monica","family":"Verdoia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tonon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Pergolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marcolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2019.09.018_bib1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pcad.2007.11.004","article-title":"Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status","volume":"50","author":"De Luca","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2019.09.018_bib2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1160\/TH04-11-0726","article-title":"Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction","volume":"93","author":"De Luca","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.numecd.2019.09.018_bib3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jacc.2009.01.053","article-title":"Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis","volume":"53","author":"De Luca","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2019.09.018_bib4","first-page":"287","article-title":"Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial","volume":"19","author":"Brener","year":"2007","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.numecd.2019.09.018_bib5","doi-asserted-by":"crossref","first-page":"e005268","DOI":"10.1136\/bmjopen-2014-005268","volume":"4","author":"Schnorbus","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.numecd.2019.09.018_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery diseasedeveloped in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.numecd.2019.09.018_bib7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"10","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.numecd.2019.09.018_bib8","first-page":"400","article-title":"Efficacy andsafety of ticagrelor for long-term secondary prevention of atherothromboticevents in relation to renal function: insights from the PEGASUS-TIMI 54 trial","volume":"37","author":"Magnani","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2019.09.018_bib9","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/01.CIR.103.21.2572","article-title":"Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study","volume":"103","author":"Steinhubl","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.09.018_bib10","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"ARCTIC Investigators. Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2019.09.018_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12265-012-9421-4","article-title":"Clinical impact of genetically determined platelet reactivity","volume":"6","author":"Laine","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.numecd.2019.09.018_bib12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1160\/TH10-05-0266","article-title":"Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment","volume":"104","author":"Bernlochner","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.numecd.2019.09.018_bib13","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2005.01364.x","article-title":"Mechanisms of homocysteine-induced atherothrombosis","volume":"3","author":"Lentz","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.numecd.2019.09.018_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/0975-3583.102695","article-title":"Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography","volume":"3","author":"Naghshtabrizi","year":"2012","journal-title":"J Cardiovasc Dis Res"},{"issue":"1","key":"10.1016\/j.numecd.2019.09.018_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/FJC.0000000000000240","article-title":"Novara atherosclerosis study group (NAS). Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid","volume":"66","author":"Verdoia","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.numecd.2019.09.018_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.numecd.2010.08.005","article-title":"Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study","volume":"22","author":"De Luca","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2019.09.018_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1751-553X.2012.01428.x","article-title":"Role of the laboratory in monitoring patients receiving dual antiplatelet therapy","volume":"34","author":"Vidali","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.numecd.2019.09.018_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Working Group on High On-Treatment Platelet Reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.numecd.2019.09.018_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/1570161113666141229115302","article-title":"Recent advances in optimal adjunctive antithrombotic therapy in STEMI patients undergoing primary angioplasty: an overview","volume":"13","author":"De Luca","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"issue":"9","key":"10.1016\/j.numecd.2019.09.018_bib20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0003319718768656","article-title":"Percutaneous versus surgical revascularization for left main or multivessel coronary artery disease: results from a large-scale meta-analysis in the era of drug-eluting stents","volume":"69","author":"Verdoia","year":"2018","journal-title":"Angiology"},{"key":"10.1016\/j.numecd.2019.09.018_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2017.06.022","article-title":"Drug-Eluting Stent in Primary angioplasty (DESERT 3) cooperation. Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"244","author":"De Luca","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2019.09.018_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2018.02.095","article-title":"Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: a meta-analysis of 11 randomized trials","volume":"264","author":"Verdoia","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2019.09.018_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2018.02.008","article-title":"Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban","volume":"164","author":"Verdoia","year":"2018","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.numecd.2019.09.018_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/FJC.0000000000000052","article-title":"Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials","volume":"63","author":"Verdoia","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.numecd.2019.09.018_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2019.02.011","article-title":"Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: a comprehensive meta-analysis of 10 randomized trials","volume":"284","author":"Verdoia","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2019.09.018_bib26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","article-title":"High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI","volume":"306","author":"Parodi","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2019.09.018_bib27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1517\/14656566.2012.666524","article-title":"Genetic and non-genetic factors affecting the response to clopidogrel therapy","volume":"13","author":"Kara\u017aniewicz-\u0141ada","year":"2012","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"10.1016\/j.numecd.2019.09.018_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/FPC.0000000000000349","article-title":"Pharmacogenetic and clinical predictors of response toclopidogrel plus aspirin after acute coronary syndrome in Egyptians","volume":"28","author":"Fathy","year":"2018","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.numecd.2019.09.018_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.vph.2015.04.014","article-title":"Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation","volume":"77","author":"Verdoia","year":"2016","journal-title":"Vascul Pharmacol"},{"issue":"2","key":"10.1016\/j.numecd.2019.09.018_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/17512433.2015.1010516","article-title":"Homocysteine and the pathogenesis of atherosclerosis","volume":"8","author":"McCully","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.numecd.2019.09.018_bib31","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on casuality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2019.09.018_bib32","article-title":"Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting","author":"Verdoia","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.numecd.2019.09.018_bib33","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1172\/JCI112519","article-title":"Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator","volume":"77","author":"Rodgers","year":"1986","journal-title":"J Clin Investig"},{"key":"10.1016\/j.numecd.2019.09.018_bib34","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V75.4.895.895","article-title":"Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells","volume":"75","author":"Rodgers","year":"1990","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.numecd.2019.09.018_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/HJH.0b013e32833778b2","article-title":"The activation of endothelin-1 pathway during methionine-induced homocysteinemia mediates endothelial dysfunction in hypertensive individuals","volume":"28","author":"Tousoulis","year":"2010","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.numecd.2019.09.018_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000353671","article-title":"Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease","volume":"36","author":"Lavall\u00e9e","year":"2013","journal-title":"Cerebrovasc Dis"},{"issue":"2\u20133","key":"10.1016\/j.numecd.2019.09.018_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijcard.2003.06.002","article-title":"Relationship of homocysteine to markers of platelet and endothelial activation in \u201chigh risk\u201d hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial","volume":"94","author":"Spencer","year":"2004","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2019.09.018_bib38","first-page":"75","article-title":"Homocysteine levels and platelet aggregation in patients with cerebral circulatory disorders","volume":"85","author":"Sabaliauskiene","year":"2013","journal-title":"Ter Arkh"},{"key":"10.1016\/j.numecd.2019.09.018_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2362.2002.00971.x","article-title":"Effect of homocysteine on arachidonic acid release in human platelets","volume":"32","author":"Signorello","year":"2002","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.numecd.2019.09.018_bib40","first-page":"59","article-title":"Effect of thiolactone homocysteine loading on adenosine metabolism in rats: relationship with platelet hyper-reactivity, correction of this metabolism disorders by vitamin-microelement complex","volume":"82","author":"Zaichko","year":"2010","journal-title":"UkrBiokhimZh"},{"key":"10.1016\/j.numecd.2019.09.018_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1160\/TH11-12-0899","article-title":"Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C\u2192T polymorphism","volume":"108","author":"Dragani","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.numecd.2019.09.018_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2013.04.010","article-title":"Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylicacid in coronary artery disease: a randomized multicenter study","volume":"74","author":"Karolczak","year":"2013","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.numecd.2019.09.018_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.33549\/physiolres.933668","article-title":"Aldosteronemodulates blood homocysteine and cholesterol in coronary artery disease patients - a possible impact on atherothrombosis?","volume":"67","author":"Karolczak","year":"2018","journal-title":"Physiol Res"},{"key":"10.1016\/j.numecd.2019.09.018_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0021-9150(95)06724-8","article-title":"Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids","volume":"121","author":"Durand","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2019.09.018_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/09537100400020187","article-title":"Homocysteinemia is inversely correlated with platelet count and directly correlated with sE- and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase","volume":"16","author":"Rongioletti","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.numecd.2019.09.018_bib46","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MBC.0b013e3283655640","article-title":"Factors influencing multiplate whole blood impedance platelet aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study","volume":"24","author":"Jastrz\u0119bska","year":"2013","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475319303576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475319303576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:10:34Z","timestamp":1760544634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475319303576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0939475319303576"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2019.09.018","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2019.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}